COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea

Given the rapid increased in confirmed coronavirus disease 2019 (COVID-19) and related mortality, it is important to identify vulnerable patients. Immunocompromised status is considered a risk factor for developing severe COVID-19. We aimed to determine whether immunocompromised patients with COVID-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2021-10, Vol.16 (10), p.e0257641-e0257641
Hauptverfasser:	Baek, Moon Seong, Lee, Min-Taek, Kim, Won-Young, Choi, Jae Chol, Jung, Sun-Young
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Biology and Life Sciences Confidence intervals Coronaviruses Corticoids Corticosteroids COVID-19 COVID-19 diagnostic tests Diabetes Disease Health insurance Heart failure HIV Hospitals Human immunodeficiency virus Hypertension Immunocompromised host Immunocompromised hosts Immunosuppressive agents Infections Internal medicine Malignancy Medicine Medicine and Health Sciences Mortality Oxygen therapy Pandemics Patient outcomes Patients Pharmacy Polymerase chain reaction Population Prescription drugs Public health Regression models Renal replacement therapy Risk analysis Risk factors Severe acute respiratory syndrome coronavirus 2 Statistical analysis Transplantation Ventilation Viral diseases Weighting
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!